U.S. flag

An official website of the United States government

NM_000298.6(PKLR):c.993C>A (p.Asp331Glu) AND not provided

Germline classification:
Pathogenic/Likely pathogenic (4 submissions)
Last evaluated:
Nov 21, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001508883.10

Allele description [Variation Report for NM_000298.6(PKLR):c.993C>A (p.Asp331Glu)]

NM_000298.6(PKLR):c.993C>A (p.Asp331Glu)

Gene:
PKLR:pyruvate kinase L/R [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q22
Genomic location:
Preferred name:
NM_000298.6(PKLR):c.993C>A (p.Asp331Glu)
HGVS:
  • NC_000001.11:g.155294358G>T
  • NG_011677.1:g.12077C>A
  • NM_000298.6:c.993C>AMANE SELECT
  • NM_181871.4:c.900C>A
  • NP_000289.1:p.Asp331Glu
  • NP_870986.1:p.Asp300Glu
  • LRG_1136t1:c.993C>A
  • LRG_1136:g.12077C>A
  • LRG_1136p1:p.Asp331Glu
  • NC_000001.10:g.155264149G>T
  • NM_000298.5:c.993C>A
  • p.Asp331Glu
Protein change:
D300E
Links:
dbSNP: rs138476691
NCBI 1000 Genomes Browser:
rs138476691
Molecular consequence:
  • NM_000298.6:c.993C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181871.4:c.900C>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001715314Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Aug 4, 2020)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

SCV002024657Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jul 18, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004252954Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 21, 2023)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

SCV004563944ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process 2024)
Likely pathogenic
(Sep 14, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot providednot providednot providedclinical testing

Citations

PubMed

Erythrocyte pyruvate kinase deficiency: 2015 status report.

Grace RF, Zanella A, Neufeld EJ, Morton DH, Eber S, Yaish H, Glader B.

Am J Hematol. 2015 Sep;90(9):825-30. doi: 10.1002/ajh.24088. Epub 2015 Aug 14. Review.

PubMed [citation]
PMID:
26087744
PMCID:
PMC5053227

Red blood cell PK deficiency: An update of PK-LR gene mutation database.

Canu G, De Bonis M, Minucci A, Capoluongo E.

Blood Cells Mol Dis. 2016 Mar;57:100-9. doi: 10.1016/j.bcmd.2015.12.009. Epub 2016 Jan 12. Review.

PubMed [citation]
PMID:
26832193
See all PubMed Citations (13)

Details of each submission

From Mayo Clinic Laboratories, Mayo Clinic, SCV001715314.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (9)

Description

PM1, PM2_supporting, PM3, PP3

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

From Revvity Omics, Revvity, SCV002024657.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV004252954.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 331 of the PKLR protein (p.Asp331Glu). This variant is present in population databases (rs138476691, gnomAD 0.03%). This missense change has been observed in individual(s) with pyruvate kinase deficiency (PMID: 7706479, 9657767, 10354117, 17360088, 29519373). ClinVar contains an entry for this variant (Variation ID: 1163643). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PKLR protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV004563944.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The PKLR c.993C>A; p.Asp331Glu variant (rs138476691) is reported in the literature in two individuals affected with PK deficiency (Baronciani 1995, Svidnicki 2018). This variant is also reported in ClinVar (Variation ID: 1163643). This variant is found in the general population with an overall allele frequency of 0.008% (24/282626 alleles) in the Genome Aggregation Database. Computational analyses predict that this variant is deleterious (REVEL: 0.942). Additionally, other variants at this codon (c.992A>G, p.Asp331Gly; c.991G>A, p.Asp331Asn) have been reported in individuals with PK deficiency and are considered disease causing (Baronciani 1998, Gupta 2007, Jamwal 2020). Based on available information, this variant is considered to be likely pathogenic. REFERENCES Baronciani L et al. Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia. J Clin Invest. 1995 Apr. PMID: 7706479 Baronciani L et al. Hematologically important mutations: red cell pyruvate kinase (2nd update). Blood Cells Mol Dis. 1998 Sep. PMID: 10087985 Gupta N et al. Prenatal diagnosis for a novel homozygous mutation in PKLR gene in an Indian family. Prenat Diagn. 2007 Feb. PMID: 17191259 Jamwal M et al. Next-Generation Sequencing-Based Diagnosis of Unexplained Inherited Hemolytic Anemias Reveals Wide Genetic and Phenotypic Heterogeneity. J Mol Diagn. 2020 Apr. PMID: 32036089 Svidnicki M et al. Novel mutations associated with pyruvate kinase deficiency in Brazil. Rev Bras Hematol Hemoter. 2018 Jan - Mar. PMID: 29519373

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 16, 2024